|
|
Article: Dr. Fariba Ghodsian Joins Trega Biosciences; Biotech Analyst Becomes Strategic and Financial Advisor
- Article from:
- PR Newswire
- Article date:
- June 6, 1997
CopyrightCOPYRIGHT 1997 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SAN DIEGO, June 6 /PRNewswire/ -- Trega Biosciences, Inc. (Nasdaq: TRGA) (formerly Houghten Pharmaceuticals, Inc.) today announced that Fariba F. Ghodsian, Ph.D., has assumed the duties of strategic and financial advisor and acting chief financial officer. She replaces Terence E. McMorrow who has resigned to pursue other opportunities. In her role, Dr. Ghodsian will be involved in investor relations, strategic planning and financial operations.
Most recently a vice president and biotechnology analyst at Lehman Brothers, Dr. Ghodsian has held similar positions at Hancock Institutional Equity Services and Wedbush Morgan Securities. Prior to Dr. Ghodsian's ...